CONCORD, N.H. (AP) - The company that makes the painkiller OxyContin is the target of a New Hampshire Attorney General's probe focused on whether the drugmaker downplays the risks of addiction.
Connecticut-based Purdue Pharma is refusing to comply with a subpoena for documents about its opioid sales and marketing of chronic pain pills in New Hampshire.
State probes whether drugmaker downplays addiction risk
Aucun commentaire:
Enregistrer un commentaire